Orthofix Appoints James F. Hinrichs to its Board of Directors
Mr. Hinrichs to Become Chair of Audit and Finance Committee
LEWISVILLE, Texas -- April 25, 2014
Orthofix International N.V. (NASDAQ:OFIX) announced today that it has
appointed James F. Hinrichs to its Board of Directors, effective immediately.
Mr. Hinrichs joins the Board with more than twenty years’ experience at
leading healthcare companies. Effective as of the Company's 2014 Annual
General Meeting of Shareholders scheduled for June 19, 2014, Mr. Hinrichs will
become the Chair of the Board's Audit and Finance Committee and a member of
its Nominating and Governance Committee. The Board has determined that Mr.
Hinrichs is independent under applicable rules of the Nasdaq Stock Market, and
qualifies as an “audit committee financial expert” under applicable rules of
the Securities and Exchange Commission. With his appointment, the Board now
includes five members who have been appointed since March 2013, four of whom
are independent, outside directors.
“Jim’s experience as a public company CFO, combined with his knowledge of the
medical device industry and related financial environment, make him an ideal
director for our Board and future Chair of our Audit and Finance Committee,”
said Orthofix Chairman Ron Matricaria. “We believe he will bring added depth
to these roles as we work to improve our reporting processes and realize our
Mr. Hinrichs has served as the Chief Financial Officer of CareFusion
Corporation since 2010, where he also has responsibility for corporate
development and investor relations activities. He previously served as
CareFusion’s Senior Vice President, Global Customer Support, and as its Senior
Vice President, Controller. Prior to joining CareFusion when it was spun off
from Cardinal Health, Inc., he worked for five years at Cardinal Health in
various positions including Executive Vice President and Corporate Controller
of Cardinal Health and as Executive Vice President and Chief Financial Officer
of its Healthcare Supply Chain Services segment. He joined Cardinal Health
following more than a decade of finance and marketing roles at Merck & Co. He
holds undergraduate and graduate degrees in business from Carnegie Mellon
Orthofix International N.V. is a diversified, global medical device company
focused on improving patients’ lives by providing superior reconstructive and
regenerative orthopedic and spine solutions to physicians worldwide.
Headquartered in Lewisville, TX, the company has four strategic business units
that include BioStim, Biologics, Extremity Fixation and Spine Fixation.
Orthofix products are widely distributed via the company’s sales
representatives, distributors and subsidiaries. In addition, Orthofix is
collaborating on research and development activities with leading clinical
organizations such as the Musculoskeletal Transplant Foundation, the
Orthopedic Research and Education Foundation and the Texas Scottish Rite
Hospital for Children. For more information, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Press spacebar to pause and continue. Press esc to stop.